Johnson & Johnson (NYSE:JNJ) Innovation has announced that it is expanding its global incubator presence through a novel collaboration with the Office of the Chief Scientist in Israel and other industry partners to establish a new biotechnology incubator near Israel’s Weizmann Science Park. Johnson & Johnson (NYSE:JNJ) stock opened at $94.17 in last session, and closed at $94.16, while the day range of stock is $93.88 – $ 94.60. The stock showed a positive weekly performance of 2.81%.
Eli Lilly & Co. (NYSE:LLY) sees its annual revenues dropping below $20 billion for the first time since 2007. Eli Lilly & Co. (NYSE:LLY) stock opened at $50.83, in last session and closed at $51.11, by losing -0.16%. The 52 week range of the stock is $47.53 – $ 58.40. Company’s market capitalization is $57.58 billion.
Merck & Co. Inc. (NYSE:MRK) announced Wednesday that a pediatric version of the HIV therapy medication Isentress has been approved by the Food and Drug Administration. Now, Isentress can be used in combination with other antiretroviral agents to treat HIV in patients four weeks of age and older. Merck & Co., Inc. (NYSE:MRK) stock decreased -0.64% and finished the last session at $49.79. The EPS of the stock remained 1.51. Company’s market capitalization is $145.72 billion.
Zacks restated their neutral rating on shares of Pfizer (NYSE:PFE) in a report issued on Tuesday, Stock Ratings Network reports. They currently have a $32.00 target price on the stock. Pfizer Inc. (NYSE:PFE) stock opened the session at $30.78, and closed the session at $30.95. The 52 week range of the stock remained $25.98 – $32.50 and the day range was $30.65 – $ 30.99.
Leave a Reply